share_log

The Analyst Verdict: OptimizeRx In The Eyes Of 6 Experts

Benzinga ·  Dec 21 02:00

Ratings for OptimizeRx (NASDAQ:OPRX) were provided by 6 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over the past 30 days and comparing them to the preceding months.

BullishSomewhat BullishIndifferentSomewhat BearishBearish
Total Ratings22200
Last 30D00100
1M Ago00000
2M Ago22100
3M Ago00000

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $8.25, along with a high estimate of $16.00 and a low estimate of $5.00. A 44.26% drop is evident in the current average compared to the previous average price target of $14.80.

bigjpg

Deciphering Analyst Ratings: An In-Depth Analysis

In examining recent analyst actions...

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment